Sohonos (palovarotene)
pCPA File Number:
22384
Negotiation Status:
Under consideration for negotiation
Indication(s):
to reduce the formation of heterotopic ossification in adults and children aged 8 years and above for females and 10 years and above for males with Fibrodysplasia (myositis) Ossificans Progressiva
Sponsor/Manufacturer:
Ipsen Biopharmaceuticals Canada, Inc.
CADTH Project Number:
SR0761
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable